Erica Wood
@ericawood.bsky.social
Head, Transfusion Research Unit, Monash University
research.monash.edu/en/persons/erica-wood
www.monash.edu/medicine/sphpm/units/transfusionresearch
Haematologist, Monash Health
monashhealth.org/services/haematology/professor-erica-wood
research.monash.edu/en/persons/erica-wood
www.monash.edu/medicine/sphpm/units/transfusionresearch
Haematologist, Monash Health
monashhealth.org/services/haematology/professor-erica-wood
Reposted by Erica Wood
Thank you so much @isbt.bsky.social!
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
November 10, 2025 at 2:05 PM
Thank you so much @isbt.bsky.social!
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
Reposted by Erica Wood
Throughout #Telomere Biology Disorder #Awareness Month, we are dedicating Fridays to spreading education and awareness. Each “Fact Friday,” we’ll highlight important science and how ongoing #research connects to care and advocacy. Today we are talking about what #telomeres are - check out our video!
November 8, 2025 at 1:58 AM
Throughout #Telomere Biology Disorder #Awareness Month, we are dedicating Fridays to spreading education and awareness. Each “Fact Friday,” we’ll highlight important science and how ongoing #research connects to care and advocacy. Today we are talking about what #telomeres are - check out our video!
Hope to see many of you at these upcoming @optimal-cre.bsky.social educational events on improving the use of immunoglobulins!
Everyone is welcome, and it's free to register.
More info below.
Everyone is welcome, and it's free to register.
More info below.
Join us this month for two online events that build capability across immunoglobulin research and care.
💡 Essentials of Health Economics in Immunoglobulin Use Workshop
🕐 10 Nov 1–3pm
🧠 Introduction to Myasthenia Gravis Webinar
🕒 24 Nov 3–4:30pm
Learn more & register: www.optimalcre.org/events
💡 Essentials of Health Economics in Immunoglobulin Use Workshop
🕐 10 Nov 1–3pm
🧠 Introduction to Myasthenia Gravis Webinar
🕒 24 Nov 3–4:30pm
Learn more & register: www.optimalcre.org/events
November 3, 2025 at 10:00 AM
Hope to see many of you at these upcoming @optimal-cre.bsky.social educational events on improving the use of immunoglobulins!
Everyone is welcome, and it's free to register.
More info below.
Everyone is welcome, and it's free to register.
More info below.
Delighted to accept the ISBT Award with Dr Allison Mo on behalf of the ISBT-SRI Transfusion Evidence Round-Up team this week in Perth!
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
October 28, 2025 at 3:03 PM
Delighted to accept the ISBT Award with Dr Allison Mo on behalf of the ISBT-SRI Transfusion Evidence Round-Up team this week in Perth!
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
@isbt.bsky.social @sritransfusion.bsky.social
More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html
Fantastic @lardr.bsky.social open meeting today at #BLOOD2025 in collaboration with Lymphoma Australia and the Australasian Lymphoma Alliance.
Thanks to everyone who participated in person or online, and for your ongoing support of the Lymphoma and Related Diseases Registry!
Thanks to everyone who participated in person or online, and for your ongoing support of the Lymphoma and Related Diseases Registry!
October 28, 2025 at 2:52 PM
Fantastic @lardr.bsky.social open meeting today at #BLOOD2025 in collaboration with Lymphoma Australia and the Australasian Lymphoma Alliance.
Thanks to everyone who participated in person or online, and for your ongoing support of the Lymphoma and Related Diseases Registry!
Thanks to everyone who participated in person or online, and for your ongoing support of the Lymphoma and Related Diseases Registry!
Congratulations Dr Jasmine Singh on receiving the 2025 Haematology Society of Australia/NZ Albert Baikie Award, recognising the best Annual Scientific Meeting presentation by a new investigator, for "longitudinal assessment of the expansion of clonal haematopoiesis of indeterminate potential".
October 28, 2025 at 2:47 PM
Congratulations Dr Jasmine Singh on receiving the 2025 Haematology Society of Australia/NZ Albert Baikie Award, recognising the best Annual Scientific Meeting presentation by a new investigator, for "longitudinal assessment of the expansion of clonal haematopoiesis of indeterminate potential".
Wonderful to be in Perth at #BLOOD2025 and the ISBT regional congress @isbt.bsky.social with some of our Monash University Transfusion Research Unit team.
We have presentations, posters and a booth!
Have a question about our research, and/or want to collaborate? Come and visit us!
We have presentations, posters and a booth!
Have a question about our research, and/or want to collaborate? Come and visit us!
October 26, 2025 at 3:31 AM
Wonderful to be in Perth at #BLOOD2025 and the ISBT regional congress @isbt.bsky.social with some of our Monash University Transfusion Research Unit team.
We have presentations, posters and a booth!
Have a question about our research, and/or want to collaborate? Come and visit us!
We have presentations, posters and a booth!
Have a question about our research, and/or want to collaborate? Come and visit us!
Important new study from the Australian and New Zealand Lymphoma and Related Diseases Registry, out now in Haematologica.
doi.org/10.3324/haem...
Nice work, Eliza Chung @lardr.bsky.social and @elizahawkes.bsky.social
doi.org/10.3324/haem...
Nice work, Eliza Chung @lardr.bsky.social and @elizahawkes.bsky.social
October 23, 2025 at 7:02 AM
Important new study from the Australian and New Zealand Lymphoma and Related Diseases Registry, out now in Haematologica.
doi.org/10.3324/haem...
Nice work, Eliza Chung @lardr.bsky.social and @elizahawkes.bsky.social
doi.org/10.3324/haem...
Nice work, Eliza Chung @lardr.bsky.social and @elizahawkes.bsky.social
Out now in JAMA Cardiol: Clonal haematopoiesis of indeterminate potential (CHIP) not associated with higher risk of cardiovascular disease in ASPREE trial, but more clinically significant bleeding.
doi:10.1001/jamacardio.2025.3756
doi:10.1001/jamacardio.2025.3756
October 18, 2025 at 9:18 PM
Out now in JAMA Cardiol: Clonal haematopoiesis of indeterminate potential (CHIP) not associated with higher risk of cardiovascular disease in ASPREE trial, but more clinically significant bleeding.
doi:10.1001/jamacardio.2025.3756
doi:10.1001/jamacardio.2025.3756
Reposted by Erica Wood
➡️ Three major RCTs (HEMOTION, TRAIN, SAHaRA) challenge restrictive transfusion dogma in brain injury.
➡️ Does the evidence now points toward a more liberal, neuroprotective threshold?
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
➡️ Does the evidence now points toward a more liberal, neuroprotective threshold?
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
October 13, 2025 at 4:52 PM
➡️ Three major RCTs (HEMOTION, TRAIN, SAHaRA) challenge restrictive transfusion dogma in brain injury.
➡️ Does the evidence now points toward a more liberal, neuroprotective threshold?
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
➡️ Does the evidence now points toward a more liberal, neuroprotective threshold?
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
Reposted by Erica Wood
Addressing power gradients (gap between those with the most & least power in a team or system) is THE most effective lever for increasing psychological safety within a team. Many ways to take action for this:
psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social
psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social
February 10, 2025 at 6:14 PM
Addressing power gradients (gap between those with the most & least power in a team or system) is THE most effective lever for increasing psychological safety within a team. Many ways to take action for this:
psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social
psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social
Reposted by Erica Wood
Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with DS, and are not acquired postnatally. buff.ly/vKCMYCm #hemesky
September 30, 2025 at 1:02 PM
Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with DS, and are not acquired postnatally. buff.ly/vKCMYCm #hemesky
Reposted by Erica Wood
WiLing Wednesday's Webinars are back! Join us for updates on various MCL topics presented by global experts, starting Oct 29 through to Nov 19.
Register on our website : womeninlymphoma.org/webinars
First session on Oct 29 : us06web.zoom.us/webinar/regi...
Register on our website : womeninlymphoma.org/webinars
First session on Oct 29 : us06web.zoom.us/webinar/regi...
September 23, 2025 at 11:31 PM
WiLing Wednesday's Webinars are back! Join us for updates on various MCL topics presented by global experts, starting Oct 29 through to Nov 19.
Register on our website : womeninlymphoma.org/webinars
First session on Oct 29 : us06web.zoom.us/webinar/regi...
Register on our website : womeninlymphoma.org/webinars
First session on Oct 29 : us06web.zoom.us/webinar/regi...
Looking forward to the next International Haemovigilance Network webinar on 21 October: "Partnering with patients is key to safer transfusion"
All are welcome, and it's free to register:
ihn-org.com/webinars/par...
All are welcome, and it's free to register:
ihn-org.com/webinars/par...
October 7, 2025 at 2:37 AM
Looking forward to the next International Haemovigilance Network webinar on 21 October: "Partnering with patients is key to safer transfusion"
All are welcome, and it's free to register:
ihn-org.com/webinars/par...
All are welcome, and it's free to register:
ihn-org.com/webinars/par...
Great to see the platelet findings from the prospective worldwide InPUT study of transfusion practice in intensive care. Just published in Crit Care Med.
doi: 10.1097/CCM.0000000000006880
@bloodsynergy.bsky.social
doi: 10.1097/CCM.0000000000006880
@bloodsynergy.bsky.social
September 27, 2025 at 11:03 PM
Great to see the platelet findings from the prospective worldwide InPUT study of transfusion practice in intensive care. Just published in Crit Care Med.
doi: 10.1097/CCM.0000000000006880
@bloodsynergy.bsky.social
doi: 10.1097/CCM.0000000000006880
@bloodsynergy.bsky.social
What is the implication of bulky disease on treatment and outcomes for patients with lymphoma? Read this analysis from the Australasian Lymphoma and Related Diseases Registry @lardr.bsky.social, led by Monash PhD student Eliza Chung.
haematologica.org/article/view...
haematologica.org/article/view...
Early View
| Haematologica
haematologica.org
September 27, 2025 at 10:48 PM
What is the implication of bulky disease on treatment and outcomes for patients with lymphoma? Read this analysis from the Australasian Lymphoma and Related Diseases Registry @lardr.bsky.social, led by Monash PhD student Eliza Chung.
haematologica.org/article/view...
haematologica.org/article/view...
Reposted by Erica Wood
⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry!
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.
September 9, 2025 at 12:43 AM
⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry!
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.
Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.
Happy to be representing the Australian Haemoglobinopathy Registry at ASCA's 4th Sickle Cell Scientific Conference.
24 October 2025, in person at Perth Children's Hospital, or online.
Everyone is welcome!
More info/registration: aussicklecelladvocacy.org
24 October 2025, in person at Perth Children's Hospital, or online.
Everyone is welcome!
More info/registration: aussicklecelladvocacy.org
September 27, 2025 at 10:37 PM
Happy to be representing the Australian Haemoglobinopathy Registry at ASCA's 4th Sickle Cell Scientific Conference.
24 October 2025, in person at Perth Children's Hospital, or online.
Everyone is welcome!
More info/registration: aussicklecelladvocacy.org
24 October 2025, in person at Perth Children's Hospital, or online.
Everyone is welcome!
More info/registration: aussicklecelladvocacy.org
Reposted by Erica Wood
🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT
📖 Read the full article here. buff.ly/AgBdW37
📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT
📖 Read the full article here. buff.ly/AgBdW37
September 23, 2025 at 3:06 PM
🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD!
📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT
📖 Read the full article here. buff.ly/AgBdW37
📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT
📖 Read the full article here. buff.ly/AgBdW37
Nice work, Dr Sarah Zhao!
Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy.
doi: 10.1016/j.clml.2025.08.004
Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy.
doi: 10.1016/j.clml.2025.08.004
September 16, 2025 at 9:16 AM
Nice work, Dr Sarah Zhao!
Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy.
doi: 10.1016/j.clml.2025.08.004
Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy.
doi: 10.1016/j.clml.2025.08.004
Thanks @who.int for emphasising the importance of preventing and treating non-communicable diseases to improve outcomes for people worldwide
⚠️Cardiovascular diseases.
⚠️Cancer.
⚠️Chronic respiratory diseases.
⚠️Diabetes.
They are silent and deadly.
Every year these diseases claim millions of lives.
Bold policies & healthier environments can stop these #SilentKillers in their tracks.
Change is within our reach 👉 bit.ly/UNGAHLM4 #UNGA
⚠️Cancer.
⚠️Chronic respiratory diseases.
⚠️Diabetes.
They are silent and deadly.
Every year these diseases claim millions of lives.
Bold policies & healthier environments can stop these #SilentKillers in their tracks.
Change is within our reach 👉 bit.ly/UNGAHLM4 #UNGA
September 16, 2025 at 9:02 AM
Thanks @who.int for emphasising the importance of preventing and treating non-communicable diseases to improve outcomes for people worldwide
Hope you can join us, in person in Perth, or online, for the Myeloma and Related Diseases Registry annual breakfast meeting, this year on Mon 27 October as part of the Blood/ISBT conference.
All are welcome and there is no cost to attend.
More info/registration link:
www.mrdr.net.au/news/mrdr-an...
All are welcome and there is no cost to attend.
More info/registration link:
www.mrdr.net.au/news/mrdr-an...
September 16, 2025 at 8:52 AM
Hope you can join us, in person in Perth, or online, for the Myeloma and Related Diseases Registry annual breakfast meeting, this year on Mon 27 October as part of the Blood/ISBT conference.
All are welcome and there is no cost to attend.
More info/registration link:
www.mrdr.net.au/news/mrdr-an...
All are welcome and there is no cost to attend.
More info/registration link:
www.mrdr.net.au/news/mrdr-an...
Reposted by Erica Wood
📰 New in research: Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors.
This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g
This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, accor...
bit.ly
September 3, 2025 at 7:47 PM
📰 New in research: Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors.
This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g
This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g
Looking forward to the Lymphoma & Related Diseases Registry @lardr.bsky.social annual breakfast meeting at BLOOD!
A partnership with Lymphoma Australia and Australasian Lymphoma Alliance.
In Perth + online on Tues 28 October.
Everyone is welcome!
Register: www.eventbrite.com.au/e/alalardrla...
A partnership with Lymphoma Australia and Australasian Lymphoma Alliance.
In Perth + online on Tues 28 October.
Everyone is welcome!
Register: www.eventbrite.com.au/e/alalardrla...
📣 Register now for the hybrid Lymphoma Breakfast Meeting!
Join us online to hear updates on our work, presented alongside the Australian Lymphoma Alliance and Lymphoma Australia.
🥐☕ Breakfast will be provided for on-site attendees.
Join us online to hear updates on our work, presented alongside the Australian Lymphoma Alliance and Lymphoma Australia.
🥐☕ Breakfast will be provided for on-site attendees.
ALA/LaRDR/LA Lymphoma Breakfast Meeting
Please join us for breakfast during BLOOD 2025
www.eventbrite.com.au
September 3, 2025 at 5:20 AM
Looking forward to the Lymphoma & Related Diseases Registry @lardr.bsky.social annual breakfast meeting at BLOOD!
A partnership with Lymphoma Australia and Australasian Lymphoma Alliance.
In Perth + online on Tues 28 October.
Everyone is welcome!
Register: www.eventbrite.com.au/e/alalardrla...
A partnership with Lymphoma Australia and Australasian Lymphoma Alliance.
In Perth + online on Tues 28 October.
Everyone is welcome!
Register: www.eventbrite.com.au/e/alalardrla...
Delighted to report that a new Centre of Research Excellence in supportive care for people with blood cancers (BloodCare) has been funded by the NHMRC!
Congratulations to chief investigator, Prof Zoe McQuilten and all our team.
Look forward to sharing more as we get started on this important work!
Congratulations to chief investigator, Prof Zoe McQuilten and all our team.
Look forward to sharing more as we get started on this important work!
September 1, 2025 at 9:46 AM
Delighted to report that a new Centre of Research Excellence in supportive care for people with blood cancers (BloodCare) has been funded by the NHMRC!
Congratulations to chief investigator, Prof Zoe McQuilten and all our team.
Look forward to sharing more as we get started on this important work!
Congratulations to chief investigator, Prof Zoe McQuilten and all our team.
Look forward to sharing more as we get started on this important work!